CCM
AUXL

Consonance Capital Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Consonance Capital Management’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,493,560
Closed -$44.6M – 29
2014
Q3 		$44.6M Buy
+1,493,560
New +$31.7M 6.12% 5

Other funds holding AUXL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Consonance Capital Management's AUXL Position: Q4 2014 in Review

Consonance Capital Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2014, closing a stake of 1,493,560 shares — an estimated $44.6M sold.

Consonance Capital Management first reported a position in AUXL in Q3 2014 and held it in 1 quarter. The position peaked at $44.6M in Q3 2014. 158 funds tracked by Wall St. Rank hold AUXL as of Q4 2014.

  • Consonance Capital Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Consonance Capital Management sold 1,493,560 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2014, an estimated $44.6M.
  • Consonance Capital Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q3 2014 and held it in 1 quarter.
  • Consonance Capital Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $44.6M in Q3 2014.
  • 158 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2014.

Based on Consonance Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.